EUVIMEDEUVIMED entdecken
Crossref

Stroke, systemic embolism, and major bleeding in patients with venous thromboembolism during Vitamin K antagonist treatment. Results from the EVENT HO study

Olga Gavín-Sebastián, Vanessa Roldán, Pilar Llamas-Sillero, Amparo Santamaría, Daniel Arumí, Susana Fernández-de-Cabo

Revista Sangre · 2022

DOI: 10.24875/sangre.21000003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Sangre, 2022. Verfasst von Olga Gavín-Sebastián und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

venous thromboembolism during vitamin K antagonist treatment. Results from the EVENTHO study

Zitieren

APA

Gavín-Sebastián, O., Roldán, V., Llamas-Sillero, P., Santamaría, A., Arumí, D., & Fernández-de-Cabo, S. (2022). Stroke, systemic embolism, and major bleeding in patients with venous thromboembolism during Vitamin K antagonist treatment. Results from the EVENT HO study. Revista Sangre. https://doi.org/10.24875/sangre.21000003

Vancouver

Gavín-Sebastián O, Roldán V, Llamas-Sillero P, Santamaría A, Arumí D, Fernández-de-Cabo S. Stroke, systemic embolism, and major bleeding in patients with venous thromboembolism during Vitamin K antagonist treatment. Results from the EVENT HO study. Revista Sangre. 2022. doi:10.24875/sangre.21000003

BibTeX
@article{GavnSebastin2022,
  author = {Gavín-Sebastián, Olga and Roldán, Vanessa and Llamas-Sillero, Pilar and Santamaría, Amparo and Arumí, Daniel and Fernández-de-Cabo, Susana},
  title = {Stroke, systemic embolism, and major bleeding in patients with venous thromboembolism during Vitamin K antagonist treatment. Results from the EVENT HO study},
  journal = {Revista Sangre},
  year = {2022},
  doi = {10.24875/sangre.21000003}
}
Kostenlos starten →